Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...
New research investigated the nervous system cell types in which putative migraine-associated genes are expressed. Lead author William Renthal, MD, PhD, answers our questions about this research.
A new study suggests that late-onset unprovoked seizures of unknown etiology may be associated with a doubled risk of developing dementia among older veterans. Neurology Consultant spoke with corresponding...
New findings suggest that tau-positron emission tomography signal can predict future brain atrophy in individuals in the early symptomatic stages of Alzheimer disease. The study’s lead author, Renaud La...
A study being presented at the ANA 2019 annual meeting highlights the connection between primary progressive aphasia and Alzheimer disease. Speaker and lead researcher Marek-Marsel Mesulam, MD, answers our...
Michael Gordon, MD, shares clinical advice for engaging with patients who have cognitive concerns ranging from subjective cognitive impairment to dementia.
Alison Goate, DPhil, answered our questions about her research on the role of genetics in Alzheimer disease onset, a topic she will also be presenting at 144th Annual Meeting of the American Neurological...
